Published in Radiology on September 16, 2005
Neglectable benefit of searching for incidental findings in the Dutch-Belgian lung cancer screening trial (NELSON) using low-dose multidetector CT. Eur Radiol (2007) 1.77
Incidental findings found in "healthy" volunteers during imaging performed for research: current legal and ethical implications. Br J Radiol (2010) 1.18
Differentiated thyroid cancer incidentally detected by ¹⁸F-FDG PET/CT: patient's future in a hot-spot? Eur J Nucl Med Mol Imaging (2014) 1.17
Potentially relevant incidental findings on research whole-body MRI in the general adult population: frequencies and management. Eur Radiol (2012) 1.13
Imaging of solitary pulmonary nodule-a clinical review. Quant Imaging Med Surg (2013) 0.98
Benign ancient schwannoma of the abdominal wall: an unwanted birthday present. BMC Surg (2010) 0.93
Indexing thoracic CT reports using a preliminary version of a standardized radiological lexicon (RadLex). J Digit Imaging (2007) 0.91
Management of incidental findings in clinical genomic sequencing. Curr Protoc Hum Genet (2013) 0.90
The fate of radiology report recommendations at a pediatric medical center. Pediatr Radiol (2017) 0.85
The use of CT for screening: a national survey of radiologists' activities and attitudes. Radiology (2008) 0.85
Non-contrast-enhanced whole-body magnetic resonance imaging in the general population: the incidence of abnormal findings in patients 50 years old and younger compared to older subjects. PLoS One (2014) 0.84
Callback and follow-up guidelines for whole-body CT screening. Radiology (2006) 0.84
Non-osseous incidental findings in low-dose whole-body CT in patients with multiple myeloma. Br J Radiol (2014) 0.82
Characterization of incidental liver lesions: comparison of multidetector CT versus Gd-EOB-DTPA-enhanced MR imaging. PLoS One (2013) 0.81
Clinical, ethical and financial implications of incidental imaging findings: experience from a phase I trial in healthy elderly volunteers. PLoS One (2012) 0.80
Radiation risks associated with serial imaging in colorectal cancer patients: should we worry? World J Gastroenterol (2014) 0.77
Ultrasonographic and laboratory screening in clinically normal mature golden retriever dogs. Can Vet J (2012) 0.77
Recommendations for additional imaging on emergency department CT examinations: comparison of emergency- and organ-based subspecialty radiologists. Emerg Radiol (2012) 0.77
Five-year malignancy incidence in patients with chronic pruritus: a population-based cohort study aimed at limiting unnecessary screening practices. J Am Acad Dermatol (2014) 0.76
What is the Significance of Indeterminate Pulmonary Nodules in Patients Undergoing Resection for Pancreatic Adenocarcinoma? J Gastrointest Surg (2015) 0.75
So rare we need to hunt for them: reframing the ethical debate on incidental findings. Genome Med (2015) 0.75
Laparoscopic excision of a preperitoneal incidentaloma. JSLS (2011) 0.75
Beyond penile cancer, is there a role for sentinel node biopsy in urological malignancies? Clin Transl Imaging (2016) 0.75
College of Radiology, Academy of Medicine of Malaysia position on whole body screening CT scans in healthy asymptomatic individuals (2008). Biomed Imaging Interv J (2008) 0.75
Radiation - friend or foe? Presidential address to Ulster Medical Society 4th October 2012. Ulster Med J (2014) 0.75
Effect of screening abdominal ultrasound examination on the decision to pursue advanced diagnostic tests and treatment in dogs with neurologic disease. J Vet Intern Med (2015) 0.75
Evidence-Based Cancer Imaging. Korean J Radiol (2017) 0.75
Renal incidental findings on computed tomography: Frequency and distribution in a large non selected cohort. Medicine (Baltimore) (2017) 0.75
Radiological findings on Irradiation-CT in patients with non metastatic breast cancer. Br J Radiol (2017) 0.75
Abdominal-pelvic scanning parameters revisited: a case for Z-axis reduction in patients with clinical suspicion for acute appendicitis. Emerg Radiol (2017) 0.75
Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med (2008) 9.32
Relaxation effects in the quantification of fat using gradient echo imaging. Magn Reson Imaging (2008) 4.13
Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial. BJU Int (2008) 3.51
Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. Radiology (2009) 3.31
Heritability of nonalcoholic fatty liver disease. Gastroenterology (2009) 3.17
Decoding global gene expression programs in liver cancer by noninvasive imaging. Nat Biotechnol (2007) 3.17
Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy. Radiology (2011) 3.08
In vivo characterization of the liver fat ¹H MR spectrum. NMR Biomed (2010) 3.07
Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial. J Natl Cancer Inst (2005) 2.82
Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging (2011) 2.75
Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T. Radiology (2011) 2.42
CT and MR imaging of extrahepatic fatty masses of the abdomen and pelvis: techniques, diagnosis, differential diagnosis, and pitfalls. Radiographics (2005) 2.37
T(1) independent, T(2) (*) corrected chemical shift based fat-water separation with multi-peak fat spectral modeling is an accurate and precise measure of hepatic steatosis. J Magn Reson Imaging (2011) 2.27
Baseline chest radiograph for lung cancer detection in the randomized Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. J Natl Cancer Inst (2005) 2.24
Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging. Radiology (2006) 2.23
Fatty liver: imaging patterns and pitfalls. Radiographics (2006) 2.21
Effect of PRESS and STEAM sequences on magnetic resonance spectroscopic liver fat quantification. J Magn Reson Imaging (2009) 2.18
Automated registration of sequential breath-hold dynamic contrast-enhanced MR images: a comparison of three techniques. Magn Reson Imaging (2011) 2.15
Pulmonary embolism at CT angiography: implications for appropriateness, cost, and radiation exposure in 2003 patients. Radiology (2010) 2.13
Advances in pediatric nonalcoholic fatty liver disease. Hepatology (2009) 2.03
Frequency of mediastinal lymphadenopathy in patients with idiopathic pulmonary arterial hypertension. Chest (2013) 2.01
Abdominal wall hernias: imaging features, complications, and diagnostic pitfalls at multi-detector row CT. Radiographics (2005) 1.98
Vertical gradients in regional lung density and perfusion in the supine human lung: the Slinky effect. J Appl Physiol (1985) (2007) 1.92
Proton density fat-fraction: a standardized MR-based biomarker of tissue fat concentration. J Magn Reson Imaging (2012) 1.90
Examining impulsivity as an endophenotype using a behavioral approach: a DRD2 TaqI A and DRD4 48-bp VNTR association study. Behav Brain Funct (2007) 1.83
SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease. Gastroenterology (2010) 1.81
Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology (2013) 1.77
Gadoxetate disodium-enhanced MRI of the liver: part 1, protocol optimization and lesion appearance in the noncirrhotic liver. AJR Am J Roentgenol (2010) 1.70
Combination of complex-based and magnitude-based multiecho water-fat separation for accurate quantification of fat-fraction. Magn Reson Med (2011) 1.67
Reproducibility of MRI-determined proton density fat fraction across two different MR scanner platforms. J Magn Reson Imaging (2011) 1.66
MR imaging of liver fibrosis: current state of the art. Radiographics (2009) 1.62
Production of pluripotent stem cells by oocyte-assisted reprogramming: joint statement with signatories. Natl Cathol Bioeth Q (2005) 1.57
Pulmonary perfusion in the prone and supine postures in the normal human lung. J Appl Physiol (1985) (2007) 1.57
Disproportionate fat stranding: a helpful CT sign in patients with acute abdominal pain. Radiographics (2004) 1.54
Quantification of liver fat with magnetic resonance imaging. Magn Reson Imaging Clin N Am (2010) 1.51
Optimal phased-array combination for spectroscopy. Magn Reson Imaging (2008) 1.48
Double-contrast MRI for accurate staging of hepatocellular carcinoma in patients with cirrhosis. AJR Am J Roentgenol (2008) 1.47
Pulmonary blood flow heterogeneity during hypoxia and high-altitude pulmonary edema. Am J Respir Crit Care Med (2004) 1.47
Fatty liver disease: MR imaging techniques for the detection and quantification of liver steatosis. Radiographics (2009) 1.46
Complete ultrasonography of trauma in screening blunt abdominal trauma patients is equivalent to computed tomographic scanning while reducing radiation exposure and cost. J Trauma Acute Care Surg (2015) 1.44
Screening US for blunt abdominal trauma: objective predictors of false-negative findings and missed injuries. Radiology (2003) 1.43
Radiogenomic analysis to identify imaging phenotypes associated with drug response gene expression programs in hepatocellular carcinoma. J Vasc Interv Radiol (2007) 1.42
Is there a role for concomitant pelvic floor repair in patients with sphincter defects in the treatment of fecal incontinence? Int J Colorectal Dis (2005) 1.40
Acute schistosomiasis in nonimmune travelers: chest CT findings in 10 patients. AJR Am J Roentgenol (2006) 1.39
Cross-sectional imaging of extranodal involvement in abdominopelvic lymphoproliferative malignancies. Radiographics (2007) 1.38
Noninvasive assessment of hepatic steatosis. Clin Gastroenterol Hepatol (2008) 1.36
Gadoxetate disodium-enhanced MRI of the liver: part 2, protocol optimization and lesion appearance in the cirrhotic liver. AJR Am J Roentgenol (2010) 1.33
CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features. Radiology (2014) 1.33
LI-RADS (Liver Imaging Reporting and Data System): summary, discussion, and consensus of the LI-RADS Management Working Group and future directions. Hepatology (2014) 1.31
Nonneoplastic lesions of the tracheobronchial wall: radiologic findings with bronchoscopic correlation. Radiographics (2002) 1.27
CT appearance of the normal appendix in adults. Eur Radiol (2005) 1.21
Advances in magnetic resonance imaging of lung physiology. J Appl Physiol (1985) (2006) 1.21
Is parastomal hernia repair with polypropylene mesh safe? Am J Surg (2003) 1.19
Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial). Hepatology (2015) 1.18
Steep head-down tilt has persisting effects on the distribution of pulmonary blood flow. J Appl Physiol (1985) (2006) 1.18
Abdominal wall hernias: MDCT findings. AJR Am J Roentgenol (2004) 1.17
Oncolytic viral therapy for prostate cancer: efficacy of reovirus as a biological therapeutic. Cancer Res (2010) 1.16
Improving quality in resource poor settings: observational study from rural Rwanda. BMJ (2009) 1.14
Characterizing pulmonary blood flow distribution measured using arterial spin labeling. NMR Biomed (2009) 1.14
Cisterna chyli at routine abdominal MR imaging: a normal anatomic structure in the retrocrural space. Radiographics (2004) 1.11
Hepatic fat quantification: a prospective comparison of magnetic resonance spectroscopy and analysis methods for chemical-shift gradient echo magnetic resonance imaging with histologic assessment as the reference standard. Invest Radiol (2012) 1.11
Cirrhosis-associated hepatocellular nodules: correlation of histopathologic and MR imaging features. Radiographics (2008) 1.10
Pediatric nonalcoholic fatty liver disease: a comprehensive review. Adv Pediatr (2010) 1.08
Imaging-based diagnostic systems for hepatocellular carcinoma. AJR Am J Roentgenol (2013) 1.08
Prostate volume and prostate-specific antigen levels in men enrolled in a large screening trial. Urology (2006) 1.07
MR contrast agents for liver imaging: what, when, how. Radiographics (2006) 1.03
Scottish Intercollegiate Guidelines Network (SIGN) guidelines on tonsillectomy: a three cycle audit of clinical record keeping and adherence to national guidelines. J Laryngol Otol (2002) 1.03
Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease. Radiology (2014) 1.02
Constraining the initial phase in water-fat separation. Magn Reson Imaging (2010) 1.02
Prostate specific antigen changes as related to the initial prostate specific antigen: data from the prostate, lung, colorectal and ovarian cancer screening trial. J Urol (2006) 1.01
CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects. Radiology (2014) 1.00
Delayed traumatic bladder rupture. AJR Am J Roentgenol (2005) 1.00
Robustness of fat quantification using chemical shift imaging. Magn Reson Imaging (2011) 0.99
Blunt abdominal trauma: clinical value of negative screening US scans. Radiology (2004) 0.98
Lung volume does not alter the distribution of pulmonary perfusion in dependent lung in supine humans. J Physiol (2010) 0.95
Effects of intravenous gadolinium administration and flip angle on the assessment of liver fat signal fraction with opposed-phase and in-phase imaging. J Magn Reson Imaging (2008) 0.95
Hypotensive patients with blunt abdominal trauma: performance of screening US. Radiology (2005) 0.95
Effect of flip angle on the accuracy and repeatability of hepatic proton density fat fraction estimation by complex data-based, T1-independent, T2*-corrected, spectrum-modeled MRI. J Magn Reson Imaging (2013) 0.94
Quantification of liver iron with MRI: state of the art and remaining challenges. J Magn Reson Imaging (2014) 0.94
Inter-examination precision of magnitude-based MRI for estimation of segmental hepatic proton density fat fraction in obese subjects. J Magn Reson Imaging (2013) 0.94
Hepatobiliary agents and their role in LI-RADS. Abdom Imaging (2015) 0.93
Diagnostic challenges and pitfalls in MR imaging with hepatocyte-specific contrast agents. Radiographics (2011) 0.93
Quantitative Assessment of Liver Fat with Magnetic Resonance Imaging and Spectroscopy. J Magn Reson Imaging (2011) 0.92
Focal hepatic lesions in Gd-EOB-DTPA enhanced MRI: the atlas. Insights Imaging (2012) 0.92
Posttransplantation lymphoproliferative disease: proposed imaging classification. Radiographics (2014) 0.92
Update on the Liver Imaging Reporting and Data System: What the Pathologist Needs to Know. Adv Anat Pathol (2015) 0.92
Acetaminophen pharmacokinetics in children with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr (2011) 0.91
Embryonic human persons. Talking Point on morality and human embryo research. EMBO Rep (2009) 0.91
Cardiac motion in diffusion-weighted MRI of the liver: artifact and a method of correction. J Magn Reson Imaging (2011) 0.91
Chest radiography with a flat-panel detector: image quality with dose reduction after copper filtration. Radiology (2005) 0.90